|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300078182 |
|
最近更新日期: Date of Last Refreshed on: |
2023-11-30 11:55:20 |
|
注册时间: Date of Registration: |
2023-11-30 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
定制式3D打印骨模型在甲状腺相关眼病外侧眼眶减压术中的应用 |
|
Public title: |
Application of customized 3D printed bone model in lateral orbital decompression surgery for thyroid related ophthalmopathy |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
定制式3D打印骨模型在甲状腺相关眼病外侧眼眶减压术中的应用 |
|
Scientific title: |
Application of customized 3D printed bone model in lateral orbital decompression surgery for thyroid related ophthalmopathy |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
余进海 |
研究负责人: |
廖洪斐 |
|
Applicant: |
yu jinhai |
Study leader: |
liao hongfei |
|
申请注册联系人电话: Applicant telephone: |
+86 158 7999 9951 |
研究负责人电话:
Study leader's |
+86 139 7009 8689 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
yujinhai1016@163.com |
研究负责人电子邮件: Study leader's E-mail: |
lhfzf@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
No. 463 Bayi Avenue, Nanchang City, Jiangxi Province, China |
研究负责人通讯地址: |
No. 463 Bayi Avenue, Nanchang City, Jiangxi Province, China |
|
Applicant address: |
No. 463 Bayi Avenue, Nanchang City, Jiangxi Province, China |
Study leader's address: |
No. 463 Bayi Avenue, Nanchang City, Jiangxi Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
330006 |
研究负责人邮政编码: Study leader's postcode: |
330006 |
|
申请人所在单位: |
南昌大学附属眼科医院 |
||
|
Applicant's institution: |
Affiliated Eye Hospital of Nanchang University |
||
|
研究负责人所在单位: |
南昌大学附属眼科医院 |
||
|
Affiliation of the Leader: |
Affiliated Eye Hospital of Nanchang University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
研伦审: 2023第(049)号: YLP20231049 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
南昌大学附属眼科医院医学研究伦理委员会 |
||
|
Name of the ethic committee: |
Medical Research Ethics Committee of Nanchang University Affiliated Ophthalmology Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-11-13 00:00:00 | ||
|
伦理委员会联系人: |
汪才皇 |
||
|
Contact Name of the ethic committee: |
wang caihuang |
||
|
伦理委员会联系地址: |
No. 463 Bayi Avenue, Nanchang City, Jiangxi Province, China |
||
|
Contact Address of the ethic committee: |
No. 463 Bayi Avenue, Nanchang City, Jiangxi Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 131 3389 6009 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
南昌大学附属眼科医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Affiliated Eye Hospital of Nanchang University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
南昌大学附属眼科医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Affiliated Eye Hospital of Nanchang University |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
江西省领先学科建设基金 |
||||||||||||||||||||||
|
Source(s) of funding: |
Jiangxi Province Leading Discipline Construction Fund |
||||||||||||||||||||||
|
研究疾病: |
甲状腺相关眼病 |
||||||||||||||||||||||
|
Target disease: |
Thyroid associated ophthalmopathy |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
通过本课题的研究,对比定制式3D打印骨模型在甲状腺相关眼病外侧眼眶减压术中的应用和传统手术组,探讨各分组患者病情改善的变化,并对患者的手术持续时间、眼球突出度、眼球运动、临床活动评分、复视情况以及术后并发症进行评估。探讨定制式3D打印骨模型在甲状腺相关眼病外侧眼眶减压术中的应用疗效。 |
||||||||||||||||||||||
|
Objectives of Study: |
Through the research of this project, the application of customized 3D printed bone models in lateral orbital decompression surgery for thyroid related eye diseases was compared with traditional surgical groups, and the changes in the improvement of patients in each group were explored. The duration of surgery, eye protrusion, eye movement, clinical activity score, diplopia, and postoperative complications of patients were evaluated. Exploring the application and therapeutic effect of customized 3D printed bone models in lateral orbital decompression surgery for thyroid related eye diseases. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
极重度或中重度静止期拟行外侧眼眶减压手术的甲状腺相关眼病的患者。 |
||||||||||||||||||||||
|
Inclusion criteria |
Patients with thyroid related eye disease who plan to undergo lateral orbital decompression surgery during extremely severe or moderate to severe stationary phase. |
||||||||||||||||||||||
|
排除标准: |
年龄小于18岁或超过65岁患者;合并全身有消耗性或免疫性基础疾病患者;担心手术风险,对手术治疗有顾忌的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Patients under 18 years old or over 65 years old; Patients with systemic wasting or immunological underlying diseases; Patients who are concerned about surgical risks and have concerns about surgical treatment. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-12-01 00:00:00至 To 2025-12-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-12-01 00:00:00 至 To 2025-11-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
按患者就诊顺序先后编号,由统计师选从“随机排列表”中,任意指定一行,依次将0-9之间的随机数字录于患者编号下(遇9以上的数字舍去)按预先规定,将随机数字为奇数者分到A组,偶数者分到B组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Number the patients in the order of their visits. The statistician selects a random row from the "random arrangement table" and records random numbers between 0 and 9 under the patient number in sequence (rounding off numbers above 9). According to the predetermined rules, odd numbers are assigned to Group A, and even numbers are assigned to Group B. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
双盲 |
|
Blinding: |
Double blinded |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
none |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
none |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集及录入软件:CRF:科研课题病例管理系统(北京利康时代科技有限公司) EDC:法默生临床研究数据采集与管理系统 PharmaSun-EDC,由同一名数据管理员完成,数据的核对由两名课题组成员负责。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection and input software: CRF: Scientific research project case management system (Beijing Likang Era Technology Co., Ltd.) EDC: PharmaSun EDC: PharmaSun EDC clinical research data collection and management system, completed by the same data administrator, and data verification is the responsibility of two research team members. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |